[Form 4] NEXT-ChemX Corporation. Insider Trading Activity
John Michael Johnson, listed as President, CFO and a Director of NEXT-ChemX Corporation (CHMX), reported changes in his beneficial ownership. The filing shows prior indirect ownership of 1,311,445 common shares reflecting a 5.5% stake in a private controlling shareholder that holds 23,844,448 CHMX shares and is subject to ongoing litigation over an earlier Form 3 claim by Sparkie Properties LLC. Johnson holds 57,473 shares directly following earlier small acquisitions priced at $1 per share. On June 30, 2025 two Subscription Agreements for 10,000 Series A and 10,000 Series F preferred shares (each $0.001 par) were recorded as disposed, with both subscription agreements never executed and terminated the same day. The Series A would have carried 500 votes and conversion into 250 common shares per preferred; Series F would have carried 1,000 votes and was non-convertible. The report is signed by Johnson on October 2, 2025.
John Michael Johnson, elencato come presidente, direttore finanziario e consigliere di NEXT-ChemX Corporation (CHMX), ha comunicato cambiamenti nella sua proprietà beneficiaria. La segnalazione mostra una precedente proprietà indiretta di 1.311.445 azioni ordinarie, riflettente una partecipazione del 5,5% in un azionista di controllo privato che detiene 23.844.448 azioni CHMX ed è soggetto a contenzioso in corso riguardo a una precedente rivendicazione Form 3 da Sparkie Properties LLC. Johnson detiene direttamente 57.473 azioni a seguito di precedenti piccoli acquisti a un prezzo di 1 dollaro per azione. Il 30 giugno 2025 sono stati registrati come disposizioni due contratti di sottoscrizione per 10.000 azioni privilegiate Serie A e 10.000 Serie F (ciascuna con valore nominale di 0,001 dollari), nessuno dei quali eseguito e terminato nello stesso giorno. La Serie A avrebbe comportato 500 voti e la conversione in 250 azioni ordinarie per azione privilegiata; la Serie F avrebbe comportato 1.000 voti ed era non convertibile. Il rapporto è firmato da Johnson il 2 ottobre 2025.
John Michael Johnson, citado como presidente, director financiero y director de NEXT-ChemX Corporation (CHMX), informó sobre cambios en su propiedad beneficiaria. La presentación muestra una propiedad indirecta previa de 1.311.445 acciones comunes que refleja una participación del 5,5% en un accionista privado que posee 23.844.448 acciones CHMX y está sujeto a un litigio en curso sobre una reclamación anterior Form 3 de Sparkie Properties LLC. Johnson posee directamente 57.473 acciones tras anteriores pequeñas compras a $1 por acción. El 30 de junio de 2025 se registraron como disposition dos Acuerdos de Suscripción para 10.000 acciones preferentes Serie A y 10.000 Serie F (cada una con valor nominal de 0,001 USD), ninguno de los cuales se ejecutó y terminaron el mismo día. La Serie A habría tenido 500 votos y conversión en 250 acciones comunes por cada acción preferente; la Serie F habría tenido 1.000 votos y era no convertible. El informe está firmado por Johnson el 2 de octubre de 2025.
John Michael Johnson은 NEXT-ChemX Corporation(CHMX)의 사장, CFO 및 이사로 등재되어 있으며, 그의 실질적 소유 지분에 변화가 있다고 보고했습니다. 서류는 1,311,445주의 간접 보유를 통해 PRIVATE 지배주주가 23,844,448주 CHMX를 보유하고 있으며 Sparkie Properties LLC의 초기 Form 3 청구에 대한 소송이 진행 중임을 반영하는 5.5%의 지분을 보여줍니다. Johnson은 이전의 소액 매수로 인해 직접 57,473주를 보유합니다. 2025년 6월 30일, 각각 표주식가 0.001달러인 시리즈 A 10,000주와 시리즈 F 10,000주를 위한 두 구독계약이 처분으로 기록되었으나 두 계약은 실행되지 않았고 같은 날 종료되었습니다. 시리즈 A는 500표를 갖고 우선주당 250주로 일반주로 전환될 수 있었으며, 시리즈 F는 1,000표를 갖고 비전환 가능했습니다. 보고서는 2025년 10월 2일에 Johnson의 서명으로 마감되었습니다.
John Michael Johnson, inscrit comme président, directeur financier et administrateur de NEXT-ChemX Corporation (CHMX), a signalé des changements dans sa propriété bénéficiaire. Le dossier montre une propriété indirecte antérieure de 1 311 445 actions ordinaires représentant une participation de 5,5 % dans un actionnaire privé contrôlant qui détient 23 844 448 actions CHMX et fait l’objet d’un litige en cours concernant une ancienne réclamation Form 3 par Sparkie Properties LLC. Johnson détient directement 57 473 actions à la suite d’avoirs précédents achetés à 1 $ par action. Le 30 juin 2025, deux accords de souscription pour 10 000 actions privilégiées Série A et 10 000 Série F (chaque action ayant une valeur nominale de 0,001 $) ont été enregistrés comme dispositions, aucun des accords n’étant exécuté et terminés le même jour. La Série A aurait comporté 500 votes et une conversion en 250 actions ordinaires par action privilégiée; la Série F aurait comporté 1 000 votes et était non convertible. Le rapport est signé par Johnson le 2 octobre 2025.
John Michael Johnson, der als Präsident, CFO und Direktor von NEXT-ChemX Corporation (CHMX) aufgeführt ist, meldete Veränderungen in seinem wirtschaftlich berechtigten Eigentum. Die Einreichung zeigt früheren indirekten Besitz von 1.311.445 Stammaktien, der eine Beteiligung von 5,5 % an einem privaten Mehrheitsaktionär widerspiegelt, der 23.844.448 CHMX-Aktien hält und Gegenstand laufender Rechtsstreitigkeiten über eine frühere Form 3-Anspruch von Sparkie Properties LLC ist. Johnson besitzt direkt 57.473 Aktien nach früheren kleineren Käufen zum Preis von 1 USD pro Aktie. Am 30. Juni 2025 wurden zwei Abonnementsverträge über 10.000 Series-A- und 10.000 Series-F-Vorzugsaktien (jeweils Nennwert 0,001 USD) als Veräußerung verzeichnet, wobei beide Verträge nie ausgeführt wurden und am selben Tag beendet wurden. Die Series A hätte 500 Stimmen und eine Umwandlung in 250 Stammaktien pro Vorzugsaktie ermöglicht; Series F hätte 1.000 Stimmen und war nicht wandelbar. Der Bericht ist von Johnson am 2. Oktober 2025 unterschrieben.
جون مايهل جونسون، المدرج كالرئيس والمدير المالي وعضو مجلس NEXT-ChemX Corporation (CHMX)، أبلغ عن تغيّرات في ملكيته المستفيدة. تُظهر الإيداع ملكية غير مباشرة سابقة تبلغ 1,311,445 سهماً عاديًا تعكس حصة قدرها 5.5% في مساهم خاص يملك 23,844,448 سهماً من CHMX وهو موضوع دعوى قضائية جارية تتعلق بمطالبة Form 3 سابقة من Sparkie Properties LLC. يمتلك جونسون 57,473 سهماً بشكل مباشر عقب عمليات شراء صغيرة سابقة بسعر 1 دولار للسهم. في 30 يونيو 2025 تم تسجيل عقدي اشتراك لـ 10,000 سهم من فئة Serie A و10,000 سهم من Serie F من الأسهم الممتازة (كلها بقيمة اسمية 0.001 دولار) كتصرف، مع عدم تنفيذ أي من العقدين وإنهائهما في اليوم نفسه. كانت Serie A ستملك 500 صوت وتحوّلًا إلى 250 سهماً عادياً لكل سهم ممتاز؛ وكانت Serie F ستملك 1,000 صوت وكانت غير قابلة للتحويل. وقع التقرير من جونسون في 2 أكتوبر 2025.
约翰·迈克尔·约翰逊，被列为 NEXT-ChemX Corporation（CHMX）的总裁、首席财务官及董事，报告其实际控制权所有权发生变动。申报显示其先前通过间接方式拥有1,311,445股普通股，代表对一名私有控股股东的5.5%股份，该股东持有23,844,448股CHMX股票，且就 Sparkie Properties LLC 早前的 Form 3 申诉存在正在进行的诉讼。约翰逊直接持有57,473股股票，此前曾以每股1美元的价格进行过小额收购。2025年6月30日，记载为处置的两份10,000股Series A与10,000股Series F优先股认购协议（每股面值0.001美元）同日未执行并终止。Series A将拥有500票并可按每份优先股换成250股普通股；Series F将拥有1,000票且不可转换。该报告由 Johnson 于2025年10月2日签署。
- Termination of preferred subscriptions removes an immediate source of potential vote concentration or dilution that would have materially changed capital structure
- Reporting of indirect and direct holdings provides transparency on the reporting person's economic and voting interests
- Ongoing litigation over Sparkie Properties' claimed ownership creates uncertainty about the controlling shareholder and voting control
- Indirect control structure (5.5% interest in the private controlling shareholder that owns 23,844,448 CHMX shares) raises governance and control transparency concerns
Insights
TL;DR: Insider holds both direct and meaningful indirect stakes; terminated preferred subscriptions and pending ownership litigation create governance uncertainty.
The filing shows John Michael Johnson combining direct holdings (57,473 common shares) with substantial indirect exposure (1,311,445 common-equivalent shares) through a controlling shareholder, representing a non-trivial ownership interest in the issuer. The terminated subscription agreements for Series A and F preferred—each 10,000 shares—would have carried disproportionate voting power if executed, so their termination removes potential immediate dilution or vote concentration but also highlights prior attempts to alter capital structure. The ongoing dispute over the Sparkie Properties ownership claim introduces legal and governance uncertainty that could affect control or voting outcomes if adjudicated. Overall, these are governance- and control-related developments rather than operating or financial-performance signals.
TL;DR: The filing raises governance questions: indirect control via a private entity and failed preferred issuances that would have concentrated voting power.
The indirect ownership tied to a private controlling shareholder (5.5% of that entity's share capital, with that entity holding 23,844,448 CHMX shares) is material from a governance perspective because it reflects potential control influence without direct public disclosure of all underlying arrangements. The canceled Subscription Agreements for Series A (500 votes per share, convertible into 250 common shares) and Series F (1,000 votes per share, non-convertible) suggest past efforts to create preferred instruments with substantial voting leverage. Termination of those agreements removes an immediate pathway to concentrated voting but the existence of litigation over claimed ownership by Sparkie Properties maintains uncertainty regarding who effectively controls the controlling shareholder and how votes will be cast in the future.
John Michael Johnson, elencato come presidente, direttore finanziario e consigliere di NEXT-ChemX Corporation (CHMX), ha comunicato cambiamenti nella sua proprietà beneficiaria. La segnalazione mostra una precedente proprietà indiretta di 1.311.445 azioni ordinarie, riflettente una partecipazione del 5,5% in un azionista di controllo privato che detiene 23.844.448 azioni CHMX ed è soggetto a contenzioso in corso riguardo a una precedente rivendicazione Form 3 da Sparkie Properties LLC. Johnson detiene direttamente 57.473 azioni a seguito di precedenti piccoli acquisti a un prezzo di 1 dollaro per azione. Il 30 giugno 2025 sono stati registrati come disposizioni due contratti di sottoscrizione per 10.000 azioni privilegiate Serie A e 10.000 Serie F (ciascuna con valore nominale di 0,001 dollari), nessuno dei quali eseguito e terminato nello stesso giorno. La Serie A avrebbe comportato 500 voti e la conversione in 250 azioni ordinarie per azione privilegiata; la Serie F avrebbe comportato 1.000 voti ed era non convertibile. Il rapporto è firmato da Johnson il 2 ottobre 2025.
John Michael Johnson, citado como presidente, director financiero y director de NEXT-ChemX Corporation (CHMX), informó sobre cambios en su propiedad beneficiaria. La presentación muestra una propiedad indirecta previa de 1.311.445 acciones comunes que refleja una participación del 5,5% en un accionista privado que posee 23.844.448 acciones CHMX y está sujeto a un litigio en curso sobre una reclamación anterior Form 3 de Sparkie Properties LLC. Johnson posee directamente 57.473 acciones tras anteriores pequeñas compras a $1 por acción. El 30 de junio de 2025 se registraron como disposition dos Acuerdos de Suscripción para 10.000 acciones preferentes Serie A y 10.000 Serie F (cada una con valor nominal de 0,001 USD), ninguno de los cuales se ejecutó y terminaron el mismo día. La Serie A habría tenido 500 votos y conversión en 250 acciones comunes por cada acción preferente; la Serie F habría tenido 1.000 votos y era no convertible. El informe está firmado por Johnson el 2 de octubre de 2025.
John Michael Johnson은 NEXT-ChemX Corporation(CHMX)의 사장, CFO 및 이사로 등재되어 있으며, 그의 실질적 소유 지분에 변화가 있다고 보고했습니다. 서류는 1,311,445주의 간접 보유를 통해 PRIVATE 지배주주가 23,844,448주 CHMX를 보유하고 있으며 Sparkie Properties LLC의 초기 Form 3 청구에 대한 소송이 진행 중임을 반영하는 5.5%의 지분을 보여줍니다. Johnson은 이전의 소액 매수로 인해 직접 57,473주를 보유합니다. 2025년 6월 30일, 각각 표주식가 0.001달러인 시리즈 A 10,000주와 시리즈 F 10,000주를 위한 두 구독계약이 처분으로 기록되었으나 두 계약은 실행되지 않았고 같은 날 종료되었습니다. 시리즈 A는 500표를 갖고 우선주당 250주로 일반주로 전환될 수 있었으며, 시리즈 F는 1,000표를 갖고 비전환 가능했습니다. 보고서는 2025년 10월 2일에 Johnson의 서명으로 마감되었습니다.
John Michael Johnson, inscrit comme président, directeur financier et administrateur de NEXT-ChemX Corporation (CHMX), a signalé des changements dans sa propriété bénéficiaire. Le dossier montre une propriété indirecte antérieure de 1 311 445 actions ordinaires représentant une participation de 5,5 % dans un actionnaire privé contrôlant qui détient 23 844 448 actions CHMX et fait l’objet d’un litige en cours concernant une ancienne réclamation Form 3 par Sparkie Properties LLC. Johnson détient directement 57 473 actions à la suite d’avoirs précédents achetés à 1 $ par action. Le 30 juin 2025, deux accords de souscription pour 10 000 actions privilégiées Série A et 10 000 Série F (chaque action ayant une valeur nominale de 0,001 $) ont été enregistrés comme dispositions, aucun des accords n’étant exécuté et terminés le même jour. La Série A aurait comporté 500 votes et une conversion en 250 actions ordinaires par action privilégiée; la Série F aurait comporté 1 000 votes et était non convertible. Le rapport est signé par Johnson le 2 octobre 2025.
John Michael Johnson, der als Präsident, CFO und Direktor von NEXT-ChemX Corporation (CHMX) aufgeführt ist, meldete Veränderungen in seinem wirtschaftlich berechtigten Eigentum. Die Einreichung zeigt früheren indirekten Besitz von 1.311.445 Stammaktien, der eine Beteiligung von 5,5 % an einem privaten Mehrheitsaktionär widerspiegelt, der 23.844.448 CHMX-Aktien hält und Gegenstand laufender Rechtsstreitigkeiten über eine frühere Form 3-Anspruch von Sparkie Properties LLC ist. Johnson besitzt direkt 57.473 Aktien nach früheren kleineren Käufen zum Preis von 1 USD pro Aktie. Am 30. Juni 2025 wurden zwei Abonnementsverträge über 10.000 Series-A- und 10.000 Series-F-Vorzugsaktien (jeweils Nennwert 0,001 USD) als Veräußerung verzeichnet, wobei beide Verträge nie ausgeführt wurden und am selben Tag beendet wurden. Die Series A hätte 500 Stimmen und eine Umwandlung in 250 Stammaktien pro Vorzugsaktie ermöglicht; Series F hätte 1.000 Stimmen und war nicht wandelbar. Der Bericht ist von Johnson am 2. Oktober 2025 unterschrieben.
FAQ
Who filed the Form 4 for CHMX and what are their roles?
How many CHMX shares does John Michael Johnson beneficially own?
What happened with the Series A and Series F preferred subscriptions?
What voting rights would the preferred shares have carried?
Is there any legal dispute noted in the filing?
